Biomea Fusion
Price & Volume
Stats
See more52W Range | $0.87-$2.99 |
Market Cap | $114.9M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.21 |
News
See moreYahoo Finance • 4 days ago
Citi Predicts Up to 410% Rally for These 2 ‘Strong Buy’ Stocks
Yahoo Finance • 21 days ago
BioMea Q2 Loss Shrinks; Data From Phase 2 Trials For Icovamenib In Diabetes Expected In '27
Yahoo Finance • 3 months ago
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study
Yahoo Finance • 4 months ago
Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights
About
CEO | Dr. Michael J. M. Hitchcock Ph.D. |
Address | 1599 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 37 |